The Zhao Lab is a newly established research group at the Lester & Sue Smith Breast Center and the Department of Molecular and Cellular Biology at Baylor College of Medicine in Houston, Texas. mRNA abundance correlates poorly with protein output, yet translational regulation remains one of the most understudied layers of cancer biology. Led by Dr. Na Zhao, the lab studies selective mRNA translation drives cancer progression, shapes the tumor immune ecosystem, and creates therapeutic vulnerabilities in primary tumor and metastatic disease.
The lab combines ribosome profiling, spatial and single-cell omics, immunocompetent mouse tumor models, patient-derived xenografts, and clinical samples to map translation dependencies across tumor evolution. Currently work on the RNA helicase eIF4A has supported the initiation of a clinical trial. The lab is currently funded by NCI, CPRIT, the Susan G. Komen, METAvivor, and Mary Kay Ash Foundation.
Baylor College of Medicine typically follows similar to the NIH stipulated stipend guidelines for Postdoctoral Associates.
Baylor College of Medicine is an Equal Opportunity/Affirmative Action/Equal Access Employer.
PD; SN